サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1206859

ホルモン補充療法市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測

Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 121 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.88円
ホルモン補充療法市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測
出版日: 2023年01月31日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン補充療法の世界市場規模は、2022年に86億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に6.26%の成長率（CAGR）を示し、2028年までに124億米ドルに達すると予測しています。

ホルモン補充療法（HRT）は、人体内に低レベルで存在するホルモンを補充するために使用されます。この治療は、成長ホルモン欠乏症の患者、閉経間近の女性、性腺機能低下症に苦しむ高齢者などに特に適しています。HRTには、皮膚や口に貼るパッチ（経皮）、ジェル、注射、インプラントなど、いくつかの形態があります。しかし、HRTは、血栓症、肝臓疾患、未治療の高血圧の既往がある患者には適さない場合があります。また、この療法には、膨満感、むくみ、吐き気、脚のけいれん、頭痛、消化不良、コレステロール値の上昇、赤血球数の増加などの副作用がある場合があります。

老人や新生児におけるホルモンバランスの乱れの急増が、主に市場成長の原動力となっています。より安全性の高い新しい治療法へのニーズの高まりは、ホルモン補充療法（HRT）の需要をさらに押し上げています。さらに、新しいゲルベースの製剤の開発とともに、主なプレーヤーによる積極的なマーケティングと直接販売キャンペーンは、これらの治療法のための魅力的な市場を作成します。さらに、消費者の意識の高まりや定期的にモニターされる製剤の存在は、市場の成長を促進する他の要因の一部となっています。

主な市場セグメンテーション

  • IMARC Groupは、ホルモン補充療法の世界市場レポートにおいて、2023年から2028年までの世界および地域レベルでの予測とともに、各サブセグメントにおける主要動向の分析を提供しています。当レポートでは、製品、投与経路、疾患のタイプに基づき市場を分類しています。

製品別の内訳

  • エストロゲン補充療法
  • ヒト成長ホルモン補充療法
  • 甲状腺補充療法
  • 男性ホルモン補充療法
  • その他
  • 製品別では、エストロゲン補充療法が市場シェアの大半を占めています。その他、ヒト成長ホルモン補充療法、テストステロン補充療法、甲状腺補充療法、その他が含まれます。

投与経路別の内訳

  • 経口
  • 非経口
  • 経皮
  • 投与経路別に、経口、非経口、経皮の各セグメントに分類しています。

疾患の種類別の内訳

  • 更年期障害
  • 甲状腺機能低下症
  • 男性性腺機能低下症
  • 成長ホルモン欠乏症
  • その他
  • 疾患別では、更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他で市場を区分しています。

地域別の内訳

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ
  • 地域別では、北米、アジア太平洋、欧州、中東・アフリカ、中南米に区分されます。このうち、北米は最大の市場であり、市場シェアの大半を占めています。

本レポートで回答した主な質問

  • 1.2022年のホルモン補充療法の世界市場規模は？
  • 2.2. 2023-2028年のホルモン補充療法の世界市場の予想成長率は？
  • 3.ホルモン補充療法の世界市場を牽引する主要因は何か？
  • 4.COVID-19がホルモン補充療法の世界市場に与えた影響とは？
  • 5.5.ホルモン補充療法の世界市場の製品別区分は？
  • 6.6.ホルモン補充療法の世界市場の投与経路に基づく区分は？
  • 7.7.ホルモン補充療法の世界市場の疾病タイプ別区分は？
  • 8.8.ホルモン補充療法の世界市場における主要地域は？
  • 9.9.ホルモン補充療法の世界市場における主要なプレイヤー/企業はどこか？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 ホルモン補充療法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 価格分析
  • 製品別市場内訳
  • 投与経路別市場内訳
  • 疾患別市場内訳
  • 地域別市場内訳
  • 市場予測
  • SWOT分析
    • 概要
    • 強み
    • 弱み
    • ビジネスチャンス
    • 脅威（スレット
  • バリューチェーン分析
    • 概要
    • 調査・研究開発
    • 原材料の調達
    • 製造
    • マーケティング
    • 流通
    • エンドユーザー
  • ポーターズファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合の度合い
    • 新規参入業者の脅威
    • 代替品の脅威

第6章 製品別市場内訳

  • エストロゲン補充療法
    • 市場動向
    • 市場予測
  • ヒト成長ホルモン補充療法
    • 市場動向
    • 市場予測
  • 甲状腺代替療法
    • 市場動向
    • 市場予測
  • 男性ホルモン補充療法
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 投与経路別市場内訳

  • 経口
    • 市場動向
    • 市場予測
  • 非経口剤
    • 市場動向
    • 市場予測
  • 経皮吸収型
    • 市場動向
    • 市場予測

第8章 疾患別市場内訳

  • 更年期障害
    • 市場動向
    • 市場予測
  • 甲状腺機能低下症
    • 市場動向
    • 市場予測
  • 男性性腺機能低下症
    • 市場動向
    • 市場展望
  • 成長ホルモン欠乏症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場展望
  • アジア太平洋地域
    • 市場動向
    • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場展望
  • ラテンアメリカ
    • 市場動向
    • 市場展望

第10章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bayer AG
    • Eli Lilly & Company
    • Roche
    • Hisamitsu Pharmaceutical Co. Inc.
    • Merck
    • Mylan NV
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
図表

List of Figures

  • Figure 1: Global: Hormone Replacement Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Hormone Replacement Therapy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Hormone Replacement Therapy Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Hormone Replacement Therapy Market: Breakup by Route of Administration (in %), 2022
  • Figure 5: Global: Hormone Replacement Therapy Market: Breakup by Type of Disease (in %), 2022
  • Figure 6: Global: Hormone Replacement Therapy Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Hormone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Hormone Replacement Therapy Industry: SWOT Analysis
  • Figure 9: Global: Hormone Replacement Therapy Industry: Value Chain Analysis
  • Figure 10: Global: Hormone Replacement Therapy Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Hormone Replacement Therapy (Estrogen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Hormone Replacement Therapy (Estrogen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Hormone Replacement Therapy (Human Growth Hormone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Hormone Replacement Therapy (Human Growth Hormone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Hormone Replacement Therapy (Thyroid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Hormone Replacement Therapy (Thyroid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Hormone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Hormone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Hormone Replacement Therapy (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Hormone Replacement Therapy (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Hormone Replacement Therapy (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Hormone Replacement Therapy (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Hormone Replacement Therapy (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Hormone Replacement Therapy (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Hormone Replacement Therapy (Transdermal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Hormone Replacement Therapy (Transdermal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Hormone Replacement Therapy (Menopause) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Hormone Replacement Therapy (Menopause) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Hormone Replacement Therapy (Hypothyroidism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Hormone Replacement Therapy (Hypothyroidism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Hormone Replacement Therapy (Male Hypogonadism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Hormone Replacement Therapy (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Hormone Replacement Therapy (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Hormone Replacement Therapy (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Europe: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Europe: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia Pacific: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia Pacific: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Middle East and Africa: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Middle East and Africa: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Latin America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Latin America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

  • Table 1: Global: Hormone Replacement Therapy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Hormone Replacement Therapy Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Hormone Replacement Therapy Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Hormone Replacement Therapy Market Forecast: Breakup by Type of Disease (in Million US$), 2023-2028
  • Table 5: Global: Hormone Replacement Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Hormone Replacement Therapy Market: Competitive Structure
  • Table 7: Global: Hormone Replacement Therapy Market: Key Players
目次
Product Code: SR1323A331_Report

The global hormone replacement therapy market size reached US$ 8.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.26% during 2023-2028.

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for (HRT) hormone replacement therapy. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global hormone replacement therapy market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, route of administration and type of disease.

Breakup by Product:

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
  • Based on product, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

Breakup by Type of Disease:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
  • On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and others.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
  • Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG, Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.
  • This report provides a deep insight into the global hormone replacement therapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hormone replacement therapy market in any manner.

Key Questions Answered in This Report:

  • 1. What was the size of the global hormone replacement therapy market in 2022?
  • 2. What is the expected growth rate of the global hormone replacement therapy market during 2023-2028?
  • 3. What are the key factors driving the global hormone replacement therapy market?
  • 4. What has been the impact of COVID-19 on the global hormone replacement therapy market?
  • 5. What is the breakup of the global hormone replacement therapy market based on the product?
  • 6. What is the breakup of the global hormone replacement therapy market based on the route of administration?
  • 7. What is the breakup of the global hormone replacement therapy market based on the type of disease?
  • 8. What are the key regions in the global hormone replacement therapy market?
  • 9. Who are the key players/companies in the global hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Price Analysis
  • 5.5 Market Breakup by Product
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Type of Disease
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Overview
    • 5.11.2 Research and Development
    • 5.11.3 Raw Material Procurement
    • 5.11.4 Manufacturing
    • 5.11.5 Marketing
    • 5.11.6 Distribution
    • 5.11.7 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Transdermal
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hypothyroidism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Male Hypogonadism
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Abbott Laboratories
    • 10.3.2 Bayer AG
    • 10.3.3 Eli Lilly & Company
    • 10.3.4 Roche
    • 10.3.5 Hisamitsu Pharmaceutical Co. Inc.
    • 10.3.6 Merck
    • 10.3.7 Mylan NV
    • 10.3.8 Novartis AG
    • 10.3.9 Novo Nordisk A/S
    • 10.3.10 Pfizer Inc.